Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Arcaini

Showing results (1-10 of 262) with videos related to

Pageof 27
Sort By:
The Lancet. Haematology|December 22, 2015
Dulanermin in indolent lymphomas: an ineffective approachLuca Arcaini
Haematologica|December 24, 2002
Management of primary mediastinal B-cell lymphoma with sclerosis: advances and caveatsLuca Arcaini, Mario Lazzarino
World Journal of Clinical Oncology|July 21, 2011
Rituximab maintenance in follicular lymphoma patientsLuca Arcaini, Michele Merli
European Journal of Haematology|July 22, 2006
A paraumbilical lymphomatous massSara Burcheri, Luca Arcaini
Haematologica|April 10, 2010
Splenic marginal zone lymphoma: hydra with many heads?Luca Arcaini, Marco Paulli
British Journal of Haematology|August 19, 2020
Direct-acting antiviral agents in lymphoproliferative disorders: more complex than expectedLuca Arcaini, Raffaele Bruno
Hematology. American Society of Hematology. Education Program|December 9, 2022
Management of marginal zone lymphomasMichele Merli, Luca Arcaini
Best Practice & Research. Clinical Haematology|February 18, 2018
Overview on the management of non-gastric MALT lymphomasIrene Defrancesco, Luca Arcaini
Haematologica|May 5, 2012
Nuclear factor-κB dysregulation in splenic marginal zone lymphoma: new therapeutic opportunitiesLuca Arcaini, Davide Rossi
Blood|August 18, 2018
Benefits and risks of JAK inhibitionLuca Arcaini, Mario Cazzola
Pageof 27

Showing results (1-10 of 262) with videos related to

Sort By:
Pageof 27
The Lancet. Haematology|December 22, 2015
Dulanermin in indolent lymphomas: an ineffective approachLuca Arcaini
Haematologica|December 24, 2002
Management of primary mediastinal B-cell lymphoma with sclerosis: advances and caveatsLuca Arcaini, Mario Lazzarino
World Journal of Clinical Oncology|July 21, 2011
Rituximab maintenance in follicular lymphoma patientsLuca Arcaini, Michele Merli
European Journal of Haematology|July 22, 2006
A paraumbilical lymphomatous massSara Burcheri, Luca Arcaini
Haematologica|April 10, 2010
Splenic marginal zone lymphoma: hydra with many heads?Luca Arcaini, Marco Paulli
British Journal of Haematology|August 19, 2020
Direct-acting antiviral agents in lymphoproliferative disorders: more complex than expectedLuca Arcaini, Raffaele Bruno
Hematology. American Society of Hematology. Education Program|December 9, 2022
Management of marginal zone lymphomasMichele Merli, Luca Arcaini
Best Practice & Research. Clinical Haematology|February 18, 2018
Overview on the management of non-gastric MALT lymphomasIrene Defrancesco, Luca Arcaini
Haematologica|May 5, 2012
Nuclear factor-κB dysregulation in splenic marginal zone lymphoma: new therapeutic opportunitiesLuca Arcaini, Davide Rossi
Blood|August 18, 2018
Benefits and risks of JAK inhibitionLuca Arcaini, Mario Cazzola
Pageof 27